Literature DB >> 16907735

Asymptomatic bacteriuria Escherichia coli strains: adhesins, growth and competition.

Viktoria Roos1, Eva M Nielsen, Per Klemm.   

Abstract

Urinary tract infections (UTIs) affect millions of people each year. Escherichia coli is the most common organism associated with asymptomatic bacteriuria (ABU) in humans. Persons affected by ABU may carry a particular E. coli strain for extended periods of time without any symptoms. In contrast to uropathogenic E. coli (UPEC) that cause symptomatic UTI, very little is known about the mechanisms by which these strains colonize the urinary tract. Here, we have investigated the growth characteristics in human urine as well as adhesin repertoire of nine ABU strains; the ability of ABU strains to compete against the UPEC strain CFT073 was also studied. The different ABU strains displayed a wide variety of the measured characteristics. Half of the ABU strains displayed functional type 1 fimbriae while only one expressed functional P fimbriae. A good correlation between the growth rate of a particular strain and the survival of the strain in competition against CFT073 was observed. Our results support the notion that for strains with reduced capacity to express fimbriae, the ability to grow fast in human urine becomes crucial for colonization of the urinary tract.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16907735     DOI: 10.1111/j.1574-6968.2006.00355.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  26 in total

Review 1.  Asymptomatic bacteriuria: when the treatment is worse than the disease.

Authors:  Barbara W Trautner
Journal:  Nat Rev Urol       Date:  2011-12-06       Impact factor: 14.432

Review 2.  Genome dynamics and its impact on evolution of Escherichia coli.

Authors:  Ulrich Dobrindt; M Geddam Chowdary; G Krumbholz; J Hacker
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

3.  Characterization of urinary tract infection-associated Shiga toxin-producing Escherichia coli.

Authors:  Francisco Toval; Roswitha Schiller; Iris Meisen; Johannes Putze; Ivan U Kouzel; Wenlan Zhang; Helge Karch; Martina Bielaszewska; Michael Mormann; Johannes Müthing; Ulrich Dobrindt
Journal:  Infect Immun       Date:  2014-08-25       Impact factor: 3.441

4.  Molecular analysis of asymptomatic bacteriuria Escherichia coli strain VR50 reveals adaptation to the urinary tract by gene acquisition.

Authors:  Scott A Beatson; Nouri L Ben Zakour; Makrina Totsika; Brian M Forde; Rebecca E Watts; Amanda N Mabbett; Jan M Szubert; Sohinee Sarkar; Minh-Duy Phan; Kate M Peters; Nicola K Petty; Nabil-Fareed Alikhan; Mitchell J Sullivan; Jayde A Gawthorne; Mitchell Stanton-Cook; Nguyen Thi Khanh Nhu; Teik Min Chong; Wai-Fong Yin; Kok-Gan Chan; Viktoria Hancock; David W Ussery; Glen C Ulett; Mark A Schembri
Journal:  Infect Immun       Date:  2015-02-09       Impact factor: 3.441

Review 5.  Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972.

Authors:  Per Klemm; Viktoria Hancock; Mark A Schembri
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

6.  Strain- and host species-specific inflammasome activation, IL-1β release, and cell death in macrophages infected with uropathogenic Escherichia coli.

Authors:  K Schaale; K M Peters; A M Murthy; A K Fritzsche; M-D Phan; M Totsika; A A B Robertson; K B Nichols; M A Cooper; K J Stacey; G C Ulett; K Schroder; M A Schembri; M J Sweet
Journal:  Mucosal Immunol       Date:  2015-05-20       Impact factor: 7.313

7.  Global gene expression profiling of asymptomatic bacteriuria Escherichia coli during biofilm growth in human urine.

Authors:  Viktoria Hancock; Per Klemm
Journal:  Infect Immun       Date:  2006-12-04       Impact factor: 3.441

8.  Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes.

Authors:  Ellaine Salvador; Florian Wagenlehner; Christian-Daniel Köhler; Alexander Mellmann; Jörg Hacker; Catharina Svanborg; Ulrich Dobrindt
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

9.  Molecular basis of commensalism in the urinary tract: low virulence or virulence attenuation?

Authors:  Jaroslaw Zdziarski; Catharina Svanborg; Björn Wullt; Jörg Hacker; Ulrich Dobrindt
Journal:  Infect Immun       Date:  2007-11-26       Impact factor: 3.441

Review 10.  Origins and virulence mechanisms of uropathogenic Escherichia coli.

Authors:  Travis J Wiles; Richard R Kulesus; Matthew A Mulvey
Journal:  Exp Mol Pathol       Date:  2008-04-08       Impact factor: 3.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.